AI assistant
Nkarta, Inc. — Director's Dealing 2020
Jul 14, 2020
33926_dirs_2020-07-13_8a6c9d9b-959e-452e-a964-ef4e9c8e5f75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nkarta, Inc. (NKTX)
CIK: 0001787400
Period of Report: 2020-07-09
Reporting Person: Rajangam Kanya (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-09 | Stock Option (right to buy) | $18.00 | A | 70600 | Acquired | 2030-07-08 | Common Stock (70600) | Direct |
Footnotes
F1: This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).